$NIOBearishMed

Beware of Nio, Xpeng, and Alibaba

After U.S. President Trump met China’s Xi, Chinese stocks fell. NIO slid to the low-$5 range after reporting non-GAAP EPS of $0.00 despite 98.8% Y/Y revenue growth to $3.7B. Xpeng reported April 2026 unit sales up 13% sequentially and said it began mass-producing robotaxis. Alibaba announced its Zhenwu AI chip M890, claiming 3x performance and 144GB GPU memory.

7/10
5/10
Med
Bearish
post-U.S.-China meeting selloff context; references recent company-specific updates (NIO earnings reaction, Xpeng robotaxi start, Alibaba chip announcement)
Risk-off tone for China/EV names; mixed company fundamentals (NIO profitability concern vs Xpeng commercialization milestone vs BABA AI hardware)

Negative earnings-quality reaction (profitability absent) reinforces downtrend risk for NIO.

Article says NIO shares slid after reporting non-GAAP EPS per ADS of $0.00 despite 98.8% Y/Y revenue growth.

Bearish near-term bias; rallies may fade while profitability remains elusive.

Background

The article links a broader China-equity selloff to U.S.-China political headlines, then highlights company-specific catalysts in EV (NIO, Xpeng) and AI hardware (Alibaba).

Why it matters

NIO is framed as losing investor confidence due to lack of profitability despite strong revenue growth; Xpeng is framed as moving from testing toward commercialization via robotaxis; Alibaba’s AI chip announcement is framed as supporting an AI pivot but without evidence of near-term monetization.

Market relevance

A risk-off China backdrop plus three distinct company catalysts creates a mixed setup: profitability concerns (NIO) vs commercialization/AI narrative support (Xpeng, BABA).

Market effects

EV and China tech/AI hardware narratives are being traded through profitability and commercialization timelines rather than top-line growth.

China-listed equities are described as pressured after U.S. President Trump met Xi, increasing headline sensitivity for ADRs/US-listed China names.

Robotics/AI and EV commercialization expectations can spill over into broader growth/tech risk appetite.

Alternative perspectives

Downtrends may already price weak profitability (NIO) and execution risk (Xpeng/BABA); specific milestones (robotaxi mass production, new AI chip) could trigger mean-reversion rallies.

The article provides no valuation, guidance, or adoption metrics; traders should verify whether robotaxis reach meaningful scale and whether BABA’s chip is tied to signed customer demand or revenue.

Key entities

  • NIO

    EV maker; shares fell after non-GAAP EPS per ADS of $0.00 despite 98.8% Y/Y revenue growth.

  • Xpeng

    EV/robotaxi company; April unit sales up 13% sequentially and robotaxi mass production started May 18.

  • Alibaba

    E-commerce/AI company; announced Zhenwu AI chip M890 with 3x performance vs 810E and 144GB GPU memory.

Related articles

$XPEVMed

Macquarie Upgrades XPeng (XPEV) to Outperform

Macquarie upgraded XPeng (NYSE:XPEV) to Outperform from Neutral on May 28, keeping its $19 price target, citing a margin-driven Q1 beat and over 2 billion yuan in other revenue tied to VW technical services, plus improving volume momentum. BofA raised its target to $25 (Buy), citing overseas sales at 20% of Q1 revenue. XPeng reported Q1 revenue of $1.89B, 62,682 deliveries, and Q2 deliveries of 100,000–106,000.

$XPEVLow

Macquarie Upgrades XPeng (XPEV) to Outperform

The article discusses AI’s potential economic impact, citing estimates from Elon Musk that 10 billion humanoid robots could be worth $250 trillion by 2040. It then claims Macquarie upgraded XPeng (XPEV) to “Outperform,” but provides no specific target price or figures. The rest is promotional content for a newsletter, including claims of past returns and “up to 400% upside” for an unnamed ~$3 stock.

$YUMMedAI 8/10

SGX-listed Jardine Matheson eyes more Asia deals after US$10 billion spree to revamp empire

Jardine Matheson Holdings (JMH) is considering further asset sales to shift from operating businesses to an investment-focused model, sources say. Mandarin Oriental International may sell the remaining Hong Kong office tower after a HK$7.2 billion sale of 13 floors to Alibaba and Ant Group. Other possible sales include its Mercedes-Benz dealership Zung Fu. JMH has proposed/completed at least US$10.5 billion in deals and shares are up over 40% in a year.

$BIDULow

Forged in a Knife Fight: China's Brutal Domestic AI Competition

The article says China’s AI push toward leadership by 2030 is shaped by both state policy and intense domestic market competition. It cites Beijing’s 15th Five-Year Plan and “AI+” initiative, but argues “involution” drives price wars, talent poaching, and provincial rivalry. Examples include ByteDance’s 99% Doubao price cut and DeepSeek’s 75% V4-Pro cut. It also notes DeepSeek talks to raise $7.35 billion and that regulators ordered Meta’s $2 billion Manus deal unwound.

$BABAMed

Chinese investors exit Hong Kong stocks as AI woos money onshore

Chinese investors cut exposure to Hong Kong-listed stocks as mainland AI shares attract capital. Bloomberg data show 25 billion yuan outflows from Hong Kong-equity ETFs via mainland exchanges last week, the largest weekly total on record. After four months of Hong Kong underperformance, Goldman Sachs downgraded H shares to market-weight, citing higher “opportunity cost” and reduced EPS growth forecasts for 2026-27.

$NIOMedAI 9/10

NIO Soars 7% on Blowout May Deliveries Up 62%, Tesla Sinks 3% as China EV Battle Intensifies

Nio reported May deliveries of 37,705 vehicles, up 62% year over year, citing demand from new launches including the ES9 SUV and AI-focused Onvo upgrades. The company’s Q1 2026 gross vehicle margin reached 19%. Nio shares rose about 7% to around $6. Tesla shares fell about 3% to ~$420.50 as China market share concerns resurfaced; Tesla said Q1 automotive gross margins rose to 21% from 16%.